We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · July 02, 2020

Effects of Combined RAAS-Inhibitor and Beta-Blocker Treatment on Outcomes in HFrEF

European Journal of Heart Failure

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Heart Failure
Effects of Combined Renin-Angiotensin-Aldosterone System Inhibitor and Beta-Blocker Treatment on Outcomes in Heart Failure With Reduced Ejection Fraction: Insights From BIOSTAT-CHF and ASIAN-HF Registries
Eur. J. Heart Fail 2020 Jun 25;[EPub Ahead of Print], W Ouwerkerk, TK Teng, J Tromp, WT Tay, JG Cleland, DJ van Veldhuisen, K Dickstein, LL Ng, CC Lang, SD Anker, F Zannad, CL Hung, JPS Sawhney, A Naik, W Shimizu, N Hagiwara, GS Wander, I Anand, AM Richards, AA Voors, CSP Lam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading